Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
42,837,925
-
Total 13F shares
-
25,162,567
-
Share change
-
-988,874
-
Total reported value
-
$65,418,419
-
Put/Call ratio
-
79%
-
Price per share
-
$2.60
-
Number of holders
-
45
-
Value change
-
+$649,419
-
Number of buys
-
21
-
Number of sells
-
19
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q4 2025
As of 31 Dec 2025,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,162,567 shares.
The largest 10 holders included
BVF INC/IL, Blue Owl Capital Holdings LP, ORBIMED ADVISORS LLC, Redmile Group, LLC, Rangeley Capital, LLC, MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and JANE STREET GROUP, LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.